Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inhibitor Therapeutics Inc. (INTI)
OTHER OTC:INTI
Inhibitor Therapeutics (INTI) Stock Price & Analysis
26 Followers
INTI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.01 - $0.30
Previous Close$0.1
Volume400.00
Average Volume (3M)17.55K
Market Cap
$16.69M
Enterprise Value$7.15M
Total Cash (Recent Filing)$9.54M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-5.5
Beta-0.10
Next Earnings
May 01, 2018EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding172,023,545
10 Day Avg. Volume2,607
30 Day Avg. Volume17,551
Standard Deviation0.43
R-Squared0.01
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)1.83
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-5.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda0.61
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
INTI FAQ
What was Inhibitor Therapeutics Inc.’s price range in the past 12 months?
Inhibitor Therapeutics Inc. lowest stock price was $0.01 and its highest was $0.30 in the past 12 months.
What is Inhibitor Therapeutics Inc.’s market cap?
Currently, no data Available
When is Inhibitor Therapeutics Inc.’s upcoming earnings report date?
Inhibitor Therapeutics Inc.’s upcoming earnings report date is May 01, 2018 which is 2186 days ago.
How were Inhibitor Therapeutics Inc.’s earnings last quarter?
Currently, no data Available
Is Inhibitor Therapeutics Inc. overvalued?
According to Wall Street analysts Inhibitor Therapeutics Inc.’s price is currently Overvalued.
Does Inhibitor Therapeutics Inc. pay dividends?
Inhibitor Therapeutics Inc. does not currently pay dividends.
What is Inhibitor Therapeutics Inc.’s EPS estimate?
Inhibitor Therapeutics Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Inhibitor Therapeutics Inc. have?
Inhibitor Therapeutics Inc. has 172,023,540 shares outstanding.
What happened to Inhibitor Therapeutics Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Inhibitor Therapeutics Inc.?
Currently, no hedge funds are holding shares in INTI
---
Inhibitor Therapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
259.25%
12-Months-Change
Fundamentals
Return on Equity
-44.57%
Trailing 12-Months
Asset Growth
-25.27%
Trailing 12-Months
Company Description
Inhibitor Therapeutics Inc.
Inhibitor Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which discovers, develops and plans to commercialize therapeutics for patients with cancer. It also explores acquiring or licensing therapeutics addressing unmet needs and orphan indications beyond cancer. The company was founded on September 30, 1992 and is headquartered in Tampa, FL.
---
Technical Analysis
---